{ "items": [ "\n\n
\n \n 31 January 2022\n \n
\n\n \n\n \n\n \n \n \n \n Health behaviours\n \n \n\n \n\n\n
\n \n\n \n \n \nBoosting the number of plant-based options can be an effective way of encouraging people to choose them and reducing meat purchase and consumption. New research finds that increasing the ratio of meat-free to meat-based meals in canteens could be a simple intervention to promote more sustainable food purchases, and is published in the International Journal of Behavioral Nutrition and Physical Activity.
\n \n\n\n \n 16 December 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Cardiovascular & metabolic\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nLed by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
\n \n\n\n \n 8 December 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Clinical trials\n \n \n \n \n Public engagement & involvement\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications \u2013 partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
\n \n\n\n \n 29 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Health Services Research\n \n \n \n \n Policy & health systems\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.
\n \n\n\n \n 12 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Cancer\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nA study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic.\r\n\r\nThe research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
\n \n\n\n \n 8 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n Cancer\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms \u2013 feeling thirsty and having dark urine \u2013 in a study presented today (Monday, 8th Jan) at the NCRI Festival.
\n \n\n\n \n 1 November 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n\n \n\n\n
\n \n\n \n \n \nAn international team of researchers, led from Centre for Evidence-based Medicine based in the Nuffield Department of Primary Care Health Sciences, University of Oxford, and funded by the World Health Organization and the National Institute for Health Research School for Primary Care Research, have today announced the findings from the most complete analysis of high-quality covid transmission studies in asymptomatic and pre-symptomatic people to date.
\n \n\n\n \n 26 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & appointments\n \n \n \n \n COVID-19\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
\n \n\n\n \n 25 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Digital health & innovation\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nResearchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
\n \n\n\n \n 21 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & appointments\n \n \n\n \n\n\n
\n \n\n \n \n \nOn Monday, the National Academy of Medicine (NAM) announced the election of 90 regular members and 10 international members during its annual meeting, including our department's very own Trish Greenhalgh. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
\n \n\n\n \n 19 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Cancer\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
\n \n\n\n \n 11 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & appointments\n \n \n \n \n COVID-19\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nA collaboration which used anonymised GP records to identify 1.5m people most at risk from Covid-19 and prioritise them for vaccination has won the prestigious John Perry Prize for computing innovation in primary care.
\n \n\n\n \n 8 October 2021\n \n
\n\n \n\n \n\n \n \n \n \n Cardiovascular & metabolic\n \n \n \n \n Policy & health systems\n \n \n\n \n\n\n
\n \n\n \n \n \nDaily meat consumption in the UK has decreased by approximately 17.4g per person per day \u2013 just under a 17% reduction \u2013 in the last decade finds new research from the University of Oxford. Between 2008/09 and 2018/19 people in the UK reduced both the amount of red and processed meat they eat, while slightly increasing their white meat consumption. Yet, this reduction is significantly less than the 30% reduction the National Food Strategy has recently called for within the next ten years.
\n \n\n\n \n 6 October 2021\n \n
\n\n \n \n \n\n \n \n \nProfessor of Primary Care Health Sciences, Trish Greenhalgh, is one of six outstanding Oxford researchers, highly commended for significant contribution to policy discussions and public understanding of COVID-19 precautions internationally, in the O2RB Excellence in Impact Awards 2021.
\n \n\n\n \n 30 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Policy & health systems\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nUse of menopausal hormone therapy (MHT), also known as hormone replacement therapy, HRT) is not associated with an increased risk of developing dementia, regardless of hormone type, dose, or duration, conclude a team of researchers from across the UK.
\n \n\n\n \n 28 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n\n \n\n\n
\n \n\n \n \n \nSmoking is highly likely to worsen the severity of COVID-19 and the risk of dying with the infection, finds a large study led by researchers from the University of Oxford and published online in the respiratory journal Thorax.
\n \n\n\n \n 23 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Awards & appointments\n \n \n\n \n\n\n
\n \n\n \n \n \nWe are delighted to announce that Jamie Hartmann-Boyce, James Sheppard and Sarah Tonkin-Crine have been awarded the title of Associate Professor, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the department and the wider Medical Sciences Division.
\n \n\n\n \n 23 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Julia Hippisley-Cox and her team have been Highly Commended in the \u2018Best use of technology in Patient Safety\u2019 category for the QCovid risk calculator at this year\u2019s Health Service Journal Patient Safety Awards.
\n \n\n\n \n 20 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Infection, Respiratory and Acute Care\n \n \n \n \n QResearch\n \n \n\n \n\n\n
\n \n\n \n \n \nNew algorithm predicts those most at risk of serious Covid-19 outcomes from 14 or more days after second vaccination dose, when substantial immunity is expected to have developed Authors hope this new risk tool will allow those who perceive risk to be high to make more informed decisions regarding shielding and potentially inform policy and clinical decisions on booster vaccine doses and monoclonal antibodies
\n \n\n\n \n 16 September 2021\n \n
\n\n \n\n \n\n \n \n \n \n Research methods & EBM\n \n \n\n \n\n\n
\n \n\n \n \n \nPublished this week is the fourth update of the Cochrane review of \u2018Electronic cigarettes for smoking cessation\u2019, and the second since it switched to a living review format in October 2020. This review brings together the most up to date research findings on the effect and safety of using electronic cigarettes to help people to stop smoking.
\n \n\n